News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

UPR-Induced Ovarian Cancer Cell Fusion: A Mechanism Favoring Drug Resistance?

News

May 26, 2023
PRESS RELEASE: On May 11, 2023, a new editorial paper was published in Oncoscience, entitled, “UPR-induced ovarian cancer cell fusion: a mechanism favoring drug resistance?” continue reading »

External Factors Shape Genetic Predisposition to Lipids, Alzheimer’s and Heart Disease in MLXIPL Gene

Aging

May 24, 2023
PRESS RELEASE: A new research paper was published in Aging's Volume 15, Issue 9, entitled, “Exogenous exposures shape genetic predisposition to lipids, Alzheimer’s, and coronary heart disease in the MLXIPL gene locus.” continue reading »

HER3: Survival Pathway and Therapeutic Target in Metastatic Colorectal and Pancreatic Cancer

News

May 24, 2023
PRESS RELEASE: On May 10, 2023, a new research perspective was published in Oncotarget, entitled, “HER3- A key survival pathway and an emerging therapeutic target in metastatic colorectal cancer and pancreatic ductal adenocarcinoma.” continue reading »

The Aging Mouse Prostate: Kinetics of Lymphocyte Infiltration

Aging

May 23, 2023
PRESS RELEASE: A new research paper was published in Aging's Volume 15, Issue 9, entitled, “Highly multiplexed immune profiling throughout adulthood reveals kinetics of lymphocyte infiltration in the aging mouse prostate.” continue reading »

GPR141 Regulates Breast Cancer Progression via Oncogenic Mediators and The p-mTOR/p53 Axis

News

May 22, 2023
PRESS RELEASE: On May 19, 2023, a new research paper was published in Oncotarget, entitled, “G-protein-coupled receptor 141 mediates breast cancer proliferation and metastasis by regulating oncogenic mediators and the p-mTOR/p53 axis.” continue reading »